Functional characterization of myeloid-derived suppressor cell subpopulations during the development of experimental arthritis

European Journal of Immunology

Volumn 45, Issue 2, 2015, Pages 464-473

  Wang, Wenhong ^a,b   Jiao, Zhijun ^a   Duan, Tanghai ^a   Liu, Meihong ^a   Zhu, Bo ^a   Zhang, Yingying ^a   Xu, Qiugui ^a   Wang, Rui ^a   Xiong, Yuyun ^a   Xu, Huaxi ^b   Lu, Liwei ^c  

^a AFFILIATED HOSPITAL OF JIANGSU UNIVERSITY   (China)

^b JIANGSU UNIVERSITY   (China)

^c UNIVERSITY OF HONG KONG   (Hong Kong)

Author keywords

Collagen induced arthritis; Myeloid derived suppressor cells; Rheumatoid arthritis; T cells

Indexed keywords

CD40 ANTIGEN; CD86 ANTIGEN; CHEMOKINE RECEPTOR CCR5; CHEMOKINE RECEPTOR CXCR2; INTERLEUKIN 10; MESSENGER RNA; TRANSFORMING GROWTH FACTOR BETA1; CD11B ANTIGEN; CD86 PROTEIN, MOUSE; CHEMOKINE RECEPTOR; GR-1 PROTEIN, MOUSE; LY ANTIGEN; LY-6C ANTIGEN, MOUSE; LY6G ANTIGEN, MOUSE;

ADOPTIVE TRANSFER; ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ARTICLE; AUTOIMMUNITY; BONE MARROW CELL; CELL EXPANSION; CONTROLLED STUDY; CYTOKINE PRODUCTION; CYTOKINE RELEASE; DISEASE ASSOCIATION; DISEASE SEVERITY; EXPERIMENTAL ARTHRITIS; IMMUNOPATHOGENESIS; IN VITRO STUDY; LYMPH NODE; LYMPHATIC DRAINAGE; LYMPHOCYTE DIFFERENTIATION; LYMPHOCYTE FUNCTION; LYMPHOCYTE PROLIFERATION; MALE; MONONUCLEAR CELL; MOUSE; MYELOID DERIVED SUPPRESSOR CELL; NONHUMAN; POLYMORPHONUCLEAR CELL; PRIORITY JOURNAL; PROTEIN EXPRESSION; SERUM; SPLEEN CELL; SUPPRESSOR CELL; T CELL DEPLETION; T LYMPHOCYTE SUBPOPULATION; TH1 CELL; TH17 CELL; ANIMAL; CD8+ T LYMPHOCYTE; CELL LINEAGE; CELL PROLIFERATION; DBA MOUSE; GENE EXPRESSION; GENETICS; IMMUNOLOGY; IMMUNOPHENOTYPING; JOINT; METABOLISM; PATHOLOGY; SPLEEN; TRANSPLANTATION;

ADOPTIVE TRANSFER; ANIMALS; ANTIGENS, CD11B; ANTIGENS, CD40; ANTIGENS, CD86; ANTIGENS, LY; ARTHRITIS, EXPERIMENTAL; CD8-POSITIVE T-LYMPHOCYTES; CELL LINEAGE; CELL PROLIFERATION; GENE EXPRESSION; IMMUNOPHENOTYPING; JOINTS; LYMPH NODES; MALE; MICE; MICE, INBRED DBA; MYELOID CELLS; RECEPTORS, CHEMOKINE; SPLEEN; TH1 CELLS; TH17 CELLS;

EID: 84923087555     PISSN: 00142980     EISSN: 15214141     Source Type: Journal    
DOI: 10.1002/eji.201444799     Document Type: Article

References (32)

1. Gabrilovich, D. I. and Nagaraj, S., Myeloid-derived suppressor cells as regulators of the immune system. Nat. Rev. Immunol. 2009. 9: 162-174.
2. Arocena, A. R., Onofrio, L.I., Pellegrini, A.V., Carrera-Silva, A.E., Paroli, A., Cano, R.C., Aoki, M.P. et al., Myeloid-derived suppressor cells are key players in the resolution of inflammation during a model of acute infection. Eur. J. Immunol. 2014. 44: 184-194.
3. Schouppe, E., Mommer, C., Movahedi, K., Laoui, D., Morias, Y., Gysemans, C., Luyckx, A. et al., Tumor-induced myeloid-derived suppressor cell subsets exert either inhibitory or stimulatory effects on distinct CD8+ T-cell activation events. Eur. J. Immunol. 2013, 43: 2930-2942.
4. Luczynski, W., Krawczuk-Rybak, M. and Stasiak-Barmuta, A., Myeloid-derived suppressor cells-the new mechanism of immunosuppression in cancer. Postepy Hig. Med. Dosw. 2008. 62: 18-22.
5. Diaz-Montero, C. M., Salem, M. L., Nishimura, M. I., Garrett-Mayer, E., Cole, D. J. and Montero, A. J., Increased circulating myeloid-derived suppressor cells correlate with clinical cancer stage, metastatic tumor burden, and doxorubicin-cyclophosphamide chemotherapy. Cancer Immunol. Immunother. 2009. 58: 49-59.
6. Solito, S., Falisi, E., Diaz-Montero, C. M., Doni, A., Pinton, L., Rosato, A., Francescato, S. et al., A human promyelocytic-like population is responsible for the immune suppression mediated by myeloid-derived suppressor cells. Blood 2011. 118: 2254-2265.
7. Fujii, W., Ashihara, E., Hirai, H., Nagahara, H., Kajitani, N., Fujioka, K., Murakami, K. et al., Myeloid-derived suppressor cells play crucial roles in the regulation of mouse collagen-induced arthritis. J. Immunol. 2013. 191: 1073-1081.
8. Zhang, L., Zhang, Z., Zhang, H., Wu, M. and Wang, Y., Myeloid-derived suppressor cells protect mouse models from autoimmune arthritis via controlling inflammatory response. Inflammation 2014. 37: 670-677.
9. Egelston, C., Kurko, J., Besenyei, T., Tryniszewska, B., Rauch, T. A., Glant, T. T. and Mikecz, K., Suppression of dendritic cell maturation and T cell proliferation by synovial fluid myeloid cells from mice with autoimmune arthritis. Arthritis Rheum. 2012. 64: 3179-3188.
10. Zhu, B., Bando, Y., Xiao, S., Yang, K., Anderson, A. C., Kuchroo, V. K. and Khoury, S. J., CD11b+Ly-6C(hi) suppressive monocytes in experimental autoimmune encephalomyelitis. J. Immunol. 2007. 179: 5228-5237.
11. Alabanza, L. M., Esmon, N. L., Esmon, C. T. and Bynoe, M. S., Inhibition of endogenous activated protein C attenuates experimental autoimmune encephalomyelitis by inducing myeloid-derived suppressor cells. J. Immunol. 2013. 191: 3764-3777.
12. Yi, H., Guo, C., Yu, X., Zuo, D. and Wang, X. Y., Mouse CD11b+Gr-1+ myeloid cells can promote Th17 cell differentiation and experimental autoimmune encephalomyelitis. J. Immunol. 2012. 189: 4295-4304.
13. Bowen, J. L. and Olson, J. K., Innate immune CD11b+Gr-1+ cells, suppressor cells, affect the immune response during Theiler's virus-induced demyelinating disease. J. Immunol. 2009. 183: 6971-6980.
14. Ioannou, M., Alissafi, T., Lazaridis, I., Deraos, G., Matsoukas, J., Gravanis, A. and Mastorodemos, V., Crucial role of granulocytic myeloid-derived suppressor cells in the regulation of central nervous system autoimmune disease. J. Immunol. 2012. 188: 1136-1146.
15. Haile, L. A., von Wasielewski, R., Gamrekelashvili, J., Kruger, C., Bachmann, O., Westendorf, A. M. and Buer, J., Myeloid-derived suppressor cells in inflammatory bowel disease: a new immunoregulatory pathway. Gastroenterology 2008. 135: 871-881.
16. Ostanin, D. V. and Bhattacharya, D., Myeloid-derived suppressor cells in the inflammatory bowel diseases. Inflamm. Bowel Dis. 2013. 19: 2468-2477.
17. Kerr, E. C., Raveney, B. J., Copland, D. A., Dick, A. D. and Nicholson, L. B., Analysis of retinal cellular infiltrate in experimental autoimmune uveoretinitis reveals multiple regulatory cell populations. J. Autoimmun. 2008. 31: 354-361.
18. Marhaba, R., Vitacolonna, M., Hildebrand, D., Baniyash, M., Freyschmidt-Paul, P. and Zoller, M., The importance of myeloid-derived suppressor cells in the regulation of autoimmune effector cells by a chronic contact eczema. J. Immunol. 2007. 179: 5071-5081.
19. Yin, B., Ma, G., Yen, C. Y., Zhou, Z., Wang, G. X., Divino, C. M. and Casares, S., Myeloid-derived suppressor cells prevent type 1 diabetes in murine models. J. Immunol. 2010. 185: 5828-5834.
20. Gao, X., Liu, H., He, B. and Fu, Z., Resistance to streptozotocin-induced autoimmune diabetes in absence of complement C3: myeloid-derived suppressor cells play a role. PLoS One 2013. 8: e66334.
21. Al-Banna, N.A., Vaci, M., Slauenwhite, D., Johnston, B. and Issekutz, T.B., CCR4 and CXCR3 play different roles in the migration of T cells to inflammation in skin, arthritic joints, and lymph nodes. Eur. J. Immunol. 2014. 44: 1633-1643.
22. Jiao, Z. J., Hua, S., Wang, W. H., Wang, H., Gao, J. J. and Wang, X. H., Increased circulating myeloid-derived suppressor cells correlated negatively with Th17 cells in patients with rheumatoid arthritis. Scand. J. Rheumatol. 2013. 42: 85-90.
23. Holmdahl, R., Malmstrom, V. and Burkhardt, H., Autoimmune priming, tissue attack and chronic inflammation-the three stages of rheumatoid arthritis. Eur. J. Immunol. 2014, 44: 1593-1599.
24. Elkabets, M., Ribeiro, V. S., Dinarello, C. A., Ostrand-Rosenberg, S., Di Santo, J. P., Apte, R. N. and Vosshenrich, C. A., IL-1beta regulates a novel myeloid-derived suppressor cell subset that impairs NK cell development and function. Eur. J. Immunol. 2010. 40: 3347-3357.
25. Youn, J. I., Nagaraj, S., Collazo, M. and Gabrilovich, D. I., Subsets of myeloid-derived suppressor cells in tumor-bearing mice. J. Immunol. 2008. 181: 5791-5802.
26. Movahedi, K., Guilliams, M., Van den Bossche, J., Van den Bergh, R., Gysemans, C., Beschin, A., De Baetselier, P. et al., Identification of discrete tumor-induced myeloid-derived suppressor cell subpopulations with distinct T cell-suppressive activity. Blood 2008. 111: 4233-4244.
27. Dolcetti, L., Peranzoni, E., Ugel, S., Marigo, I., Fernandez, G. A., Mesa, C., Geilich, M. et al., Hierarchy of immunosuppressive strength among myeloid-derived suppressor cell subsets is determined by GM-CSF. Eur. J. Immunol. 2010. 40: 22-35.
28. Peranzoni, E., Zilio, S., Marigo, I., Dolcetti, L., Zanovello, P., Mandruzzato, S. and Bronte, V., Myeloid-derived suppressor cell heterogeneity and subset definition. Curr. Opin. Immunol. 2010. 22: 238-244.
29. Serafini, P., Myeloid derived suppressor cells in physiological and pathological conditions: the good, the bad, and the ugly. Immunol. Res. 2013. 57: 172-184.
30. Kallberg, E., Stenstrom, M., Liberg, D., Ivars, F. and Leanderson, T., CD11b+Ly6C++Ly6G- cells show distinct function in mice with chronic inflammation or tumor burden. BMC Immunol. 2012. 13: 69.
31. Deng, J., Liu, Y., Yang, M., Wang, S., Zhang, M., Wang, X. and Ko, K. H., Leptin exacerbates collagen-induced arthritis via enhancement of Th17 cell response. Arthritis Rheum. 2012. 64: 3564-3573.
32. Lai Kwan Lam, Q., King Hung Ko, O., Zheng, B. J. and Lu, L.W., Local BAFF gene silencing suppresses Th17-cell generation and ameliorates autoimmune arthritis. Proc. Natl. Acad. Sci. USA 2008. 105: 14993-14998.